Pilot study to test usability of wearable biosensor in elderly with non-specific complaints

Pilot study to test usability of wearable biosensor in elderly with non-specific complaints -

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON20672

Enrollment

Registered

2016-07-21

Start date

2016-09-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

elderly with non-specific complaints

Interventions

The participants will wear a wearable biosensor that will record the vital parameters continuously

Eligibility

Inclusion criteria

Inclusion criteria: Group 1: Optimal triage in the pre-hospital setting • Age ≥ 65 years; • Patient at the GP’s office with non-specific complaint(s) only; • Patient living in a home residence with/without home care or home residence; • ISAR score ≥ 2; • Informed consent. Group 2: Follow-up of discharged patients from the internal medicine ward/ED. • Age ≥ 65 years; • Registered at the ED for Internal Medicine or patients will be discharged from the hospital; • Patients do not present with specific complaints; • Patients are ready for discharge home; • Patients living at home (with/without home care) or home residence; • ISAR ≥3; • Informed consent. Group 3: Control • Age ≥ 65 years; • Informed consent.

Exclusion criteria

Exclusion criteria: Group 1: Optimal triage in the pre-hospital setting • Patients with positive anamnesis and/or medical examination for specific complaints; • Age < 65 year; • Patients with life expectancy <3 months (terminally ill patients); • ISAR score <2. • Patients who have implanted defibrillators or pacemakers • Damaged or very vulnerable skin around patch location • Allergic to silicone or hydrocolloid adhesive materials Group 2: Follow-up of discharged patients from the internal medicine ward/ED. • Age < 65 years; • Other specialties besides internal medicine; • Patients with diagnosed dementia; • Patients living in a nursing home; • Patients with an active oncologic disease; • Patients with a live expectancy of less than 3 months; • ISAR <3 score. • Patients who have implanted defibrillators or pacemakers • Damaged or very vulnerable skin around patch location • Allergic to silicone or hydrocolloid adhesive materials Group 3: Control • Age < 65 year; • Co-morbidities • Patients with life expectancy <3 months (terminally ill patients); • Patients who have implanted defibrillators or pacemakers • Damaged or very vulnerable skin around patch location • Allergic to silicone or hydrocolloid adhesive materials

Design outcomes

Primary

Measure	Time frame
To assess the successful usage of the wearable biosensor with the smartphone app (i.e. patient feedback, caregiver feedback, raw device data, technical operational data),	—

Secondary

Measure	Time frame
The frailty index	—

Contacts

Public ContactCeline Reverseau

Philips Research Eindhoven

celine.reverseau@philips.comm:+31-6-31639778

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)